drugset / Trial / NCT05046561
Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial
RandomizedSingle-groupTriple-blindTreatment
Summary
Protocol STRI12 - Study to Reinforce Immunity (STRI) - A Phase 2 Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of STRI Formula in Non-Hospitalized Participants with COVID-19 (the Study)
Timeline
- Start
- 2021-11-04
- Primary completion
- 2022-12
- Completion
- 2023-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | STRI Formula | Other / unclassified | — | Oral |